JOHN FREDERICK DE GROOT to Fibronectins
This is a "connection" page, showing publications JOHN FREDERICK DE GROOT has written about Fibronectins.
Connection Strength
0.131
-
Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma. Invest New Drugs. 2015 Feb; 33(1):247-53.
Score: 0.116
-
Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma. Mol Cancer Ther. 2005 Nov; 4(11):1681-8.
Score: 0.015